期刊
EUROPEAN JOURNAL OF HUMAN GENETICS
卷 11, 期 2, 页码 201-206出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.ejhg.5200935
关键词
Noonan; PTPN11; SHP-2; CFC
Noonan syndrome (NS) is a relatively common, but genetically heterogeneous autosomal dominant malformation syndrome. Characteristic features are proportionate short stature, dysmorphic face, and congenital heart defects. Only recently, a gene involved in NS could be identified. It encodes the nonreceptor protein tyrosine phosphatase SHP-2, which is an important molecule in several intracellular signal transcluction pathways that control diverse developmental processes, most importantly cardiac semilunar valvulogenesis. We have screened this gene for mutations in 96 familial and sporadic, well-characterised NS patients and identified 15 different missense mutations in a total of 32 patients (33%), including 23 index patients. Most changes clustered in one exon which encodes parts of the N-SH2 domain. Five of the mutations were recurrent. Interestingly, no mutations in the PTPN11 gene were detected in five additional patients with cardio-facio-cutaneous (CFC) syndrome, which shows clinical similarities to NS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据